# Randomized Clinical Trial on Clinical Management of ASCUS and LSIL (ALTS)

> **NCT01131312** · PHASE3 · COMPLETED · sponsor: **National Cancer Institute (NCI)** · enrollment: 5060 (actual)

## Conditions studied

- Cervical Intraepithelial Neoplasia

## Interventions

- **DEVICE:** Thinprep
- **DEVICE:** Hybrid capture 2
- **PROCEDURE:** Colposcopy

## Key facts

- **NCT ID:** NCT01131312
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-02-20
- **Primary completion:** 2009-02-05
- **Final completion:** 2009-02-05
- **Target enrollment:** 5060 (ACTUAL)
- **Last updated:** 2018-11-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01131312

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01131312, "Randomized Clinical Trial on Clinical Management of ASCUS and LSIL (ALTS)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01131312. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*